3:50 PM
Jan 28, 2019
 |  BC Extra  |  Company News

Management tracks: Ironwood reveals board for new companies

Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD) named Mark Currie as incoming president of its spinout Cyclerion Therapeutics Inc. Currie will also join Ironwood's board following the separation, which is on track to occur this half. He is currently Ironwood's SVP, CSO and president of R&D (see "Splitting Ironwood").

Upon the split, Ironwood expects its board to also appoint incoming CEO Mark Mallon, Jon Duane, Marla Kessler and Catherine Moukheibir as new directors. They will join existing Chairperson Julie McHough and existing directors Andrew Dreyfus, Lawrence Olanoff and Edward Owens.

Marsha Fanucci, Ironwood co-founder and CEO Peter Hecht,Terrance McGuire...

Read the full 464 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >